Hydroxychloroquine on the Pulmonary Vascular Diseases in Interstitial Lung Disease: Immunologic Effects, and Virus Interplay

To investigate the effects of hydroxychloroquine (HCQ) drug use on the risk of pulmonary vascular disease (PVD) in an interstitial lung disease cohort (ILD cohort, ILD+ virus infection), we retrospectively enrolled the ILD cohort with HCQ (HCQ users, N = 4703) and the ILD cohort without HCQ (non-HCQ...

Descripción completa

Detalles Bibliográficos
Autores principales: Yeh, Jun-Jun, Syue, Shih-Hueh, Sun, Yi-Fun, Yeh, Yi-Ting, Zheng, Ya-Chi, Lin, Cheng-Li, Hsu, Chung Y., Kao, Chia-Hung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9219797/
https://www.ncbi.nlm.nih.gov/pubmed/35740313
http://dx.doi.org/10.3390/biomedicines10061290

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9219797/
https://www.ncbi.nlm.nih.gov/pubmed/35740313
http://dx.doi.org/10.3390/biomedicines10061290

Ejemplares similares